Avid Bioservices Inc (CDMO)

[entdoc]

geocappy, good question. King's "disconnect" is probably the huge difference between MOS in pancreatic, and that in most other cancers. More specifically, he was probably alluding the difference in Bavi trials in first line lung cancer and pancreatic. He would not speak of the difference between pancreatic cancer and 2nd line cancer as a disconnect, or a huge difference in MOS. I traced this thread back to mojojo 111106. Very interesting. For those here who question why big dollars aren't pouring/pooring? into PPHM stock...I'm with you. At this point most people conversant with PPHM product would think it a great bet. The biotech speculative market must be off considerably...or is it just PPHM? Anyone?